For CBH’s full webpage of COVID-19 information and resources, click here.
OMHSAS Visitation Guidance for RTF, LTSR, and CRR
Yesterday, the Office of Mental Health and Substance Abuse Services (OMHSAS) released a memo regarding visitation guidelines under COVID-19 for residential treatment including Long-Term Structured Residences (LTSR), Community Residential Rehabilitation (CRR) Services, Residential Treatment Facilities for Adults (RTF-A), and Crisis Residences. View the full memo here.
For visitation guidelines for children and youth residential treatment, refer to the related March 26 OMHSAS memo here.
DEA Policy: Use of Telephone Evaluations to Initiate Buprenorphine Prescribing
Yesterday, in cooperation with the Substance Abuse and Mental Health Services Administration (SAMHSA), the Drug Enforcement Agency (DEA) released guidance stating that practitioners have further flexibility during the nationwide public health emergency to prescribe buprenorphine to new and existing patients with OUD via telephone by otherwise authorized practitioners without requiring such practitioners to first conduct an examination of the patient in person or via telemedicine.
View the full guidance document here.
CBH Provider Bulletin 20-08: COVID-19 Response: Alternative Payment Arrangement
CBH Released a Bulletin and supporting documents regarding the Alternative Payment Arrangement (APA):
- CBH Bulletin 20-08: COVID-19 Response: Alternative Payment Arrangement (published April 1, 2020)
- APA Supporting Documents and Expense Tracking Spreadsheet